Rankings
▼
Calendar
CCEL Q3 2016 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena
CCEL
Cryo-Cell International, Inc.
$25M
Q3 2016 Earnings
Healthcare
Medical - Care Facilities
Income Statement
Revenue
$6M
Gross Profit
$5M
75.5% margin
Operating Income
-$1M
-16.8% margin
Net Income
-$3M
-41.8% margin
EPS (Diluted)
$-0.35
QoQ Revenue Growth
+9.7%
Cash Flow
Operating Cash Flow
$1M
Free Cash Flow
$1M
Stock-Based Comp.
$433,301
Balance Sheet
Total Assets
$18M
Total Liabilities
$35M
Stockholders' Equity
-$17M
Cash & Equivalents
$2M
Revenue Segments
Umbilical Cord Blood And Cord Tissue Stem Cell Service
$6M
99%
Prepacyte-CB
$88,135
1%
Geographic Segments
INDIA
$609,045
100%
← FY 2016
All Quarters
Q4 2016 →
